All articles by Anthony King – Page 16
-
NewsRoadmap to reward pharma for creating new antibiotics unveiled
Report recommends large up-front payments and an innovation fund for blue skies research to tackle microbial resistance
-
BusinessMerger creates biggest supplier of unlicensed drugs
Clinigen will buy Idis to consolidate different routes by which doctors can access medicines that are unavailable locally
-
ResearchChemicals formed on meteorites may have started life on Earth
Simple chemical turned into DNA bases and other precursors to life on simulated meteorite surface
-
NewsReview plots path to face down antimicrobial resistance deaths
Billion dollar innovation fund called for to kick-start antimicrobial drug research in the UK
-
NewsAntimicrobial resistance will kill 300 million by 2050 without action
UK report says resistance will cost global economy $100 trillion
-
ResearchSmart skin for prosthetic limbs senses heat and touch
Ultra-thin plastic skin can bend and flex without affecting the skin’s ability to detect stimuli
-
BusinessCystic Fibrosis Foundation sells drug royalty rights for $3.3bn
‘Venture philanthropy’ model pays off with massive cash injection for charity
-
ResearchHomes can wrap up warm with super-insulating foam
Graphene oxide, clay and cellulose nanofibres turned into a cheap, fireproof insulator that performs better than conventional materials
-
BusinessIneos bets big on shale
UK profit-sharing plan and transatlantic ethane shipping contracts show company’s commitment to a fracking future
-
NewsSwiss readmitted to Europe's huge science programme
Spat over immigration from the EU smoothed over for now, but partial re-entry to Horizon 2020 may not last
-
ResearchDebate over microwave boost to reactions rumbles on
New research claims microwave-specific heating effect is real and down to localised heating of reactants
-
NewsCost of scientific misconduct smaller than feared
Analysis puts a price on misconduct for US funder and claims it only comes to $58 million over 10 years
-
BusinessPharma firms rush to escape US tax shackles
AbbVie–Shire and Mylan–Abbott mergers both allow US firms to escape to lower-tax European countries
-
NewsCall for new models to pay for antibiotics
UK government report on ways to fight resistance follows prime minister’s call for global action
-
Business
Drug giants settle mismarketing lawsuits
Pfizer and GSK settle claims over promoting drugs for unapproved uses in the US
-
NewsGlowing roads take a rain check
Moisture seeping into the photoluminescent strips dampens their illumination
-
NewsUncertainty dogs Swiss science in EU immigration row
No end in sight to impasse on Switzerland’s participation in European research and education programmes
-
NewsMetrics' role in assessing research reviewed
UK higher education body launches investigation into the pros and cons of metrics in managing research
-
NewsAnalysts shrug off rare earth trade ruling
WTO’s indictment of Chinese export duties won’t affect export market, experts say
-
Research
Californium compound springs bonding surprise
Borate material shows previously unseen f-orbital involvement in bonding